Posted in | News | Electronics

MKS Instruments Announces Closing of Atotech Acquisition

MKS Instruments, Inc. (NASDAQ: MKSI) (“MKS”), a global provider of technologies that enable advanced processes and improve productivity, today announced the completion of the previously announced acquisition of Atotech Limited (NYSE: ATC) (“Atotech”) for approximately $4.4 billion in cash and MKS common stock. Atotech is a global leader in process chemicals, equipment, software and services for printed circuit boards, semiconductor IC packaging, and surface finishing.

“The acquisition of Atotech positions MKS to accelerate roadmaps for future generations of advanced electronics devices. By combining leading capabilities in lasers, optics, motion and now process chemistry, MKS is set to be a leader in the next frontier for miniaturization and complexity: Optimizing the InterconnectSM, a significant enabling point of next-generation advanced electronics. Atotech’s leadership in functional and decorative surface finishing will also extend MKS’ product offering for industrial applications and grow our market reach. I could not be more excited to welcome the Atotech team to the MKS family.” 

John T.C. Lee, President and CEO of MKS

The acquisition was effected by means of a scheme of arrangement under the laws of the Bailiwick of Jersey (the “Scheme”). As previously announced, on August 15, 2022, the Royal Court of Jersey issued a court order (the “Court Order”) sanctioning the Scheme. Completion of the acquisition occurred earlier today upon the Court Order being delivered to the registrar of companies for the Bailiwick of Jersey.

Accretion Expectations

The combination of MKS and Atotech creates a company with pro forma revenue of $4.5 billion for the twelve months ended June 30, 2022. As a result of higher interest rates on debt financing compared to the time the transaction was originally announced in July 2021, as well as the impact of the current macroeconomic and inflationary environment on our business, MKS currently anticipates the acquisition will be accretive to Non-GAAP diluted net earnings per share for the full fiscal year 2024.

About MKS Instruments

MKS Instruments enables technologies that transform our world. We deliver foundational technology solutions to leading edge semiconductor manufacturing, advanced electronics and specialty industrial applications. We apply our broad science and engineering capabilities to create instruments, subsystems, systems, process control solutions and specialty chemicals technology that improve process performance, optimize productivity and enable unique innovations for many of the world’s leading technology and industrial companies.

Our solutions are critical to addressing the challenges of miniaturization and complexity in advanced device manufacturing by enabling increased power, speed and feature enhancement for optimized connectivity. Our solutions are also critical to addressing ever-increasing performance requirements across a wide array of specialty industrial applications. Additional information can be found at https://www.mks.com.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    MKS Instruments, Inc.. (2022, August 18). MKS Instruments Announces Closing of Atotech Acquisition. AZoM. Retrieved on November 21, 2024 from https://www.azom.com/news.aspx?newsID=59787.

  • MLA

    MKS Instruments, Inc.. "MKS Instruments Announces Closing of Atotech Acquisition". AZoM. 21 November 2024. <https://www.azom.com/news.aspx?newsID=59787>.

  • Chicago

    MKS Instruments, Inc.. "MKS Instruments Announces Closing of Atotech Acquisition". AZoM. https://www.azom.com/news.aspx?newsID=59787. (accessed November 21, 2024).

  • Harvard

    MKS Instruments, Inc.. 2022. MKS Instruments Announces Closing of Atotech Acquisition. AZoM, viewed 21 November 2024, https://www.azom.com/news.aspx?newsID=59787.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.